Answers are grounded in this paper and cite their sources.
A new immunoblot assay, composed of four Epstein-Barr virus (EBV)-encoded recombinant proteins (virus capsid antigen [VCA] p23, early antigen [EA] p138, EA p54, and EBNA-1 p72), was compared with an immunofluorescence assay on a total of 291 sera. The test was accurate in 94.5% of cases of primary EBV infection, while an immunoglobulin G anti-VCA p23 band with strong intensity correlated with reactivation.
No takes yet. Share an insight, caveat, or question.
Buisson et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: